Suzuki S, Uchiyama K, Motoi Y, Yoshii Y, Inoue Y, Kubota T
BMC Gastroenterol. 2023; 23(1):239.
PMID: 37454061
PMC: 10350251.
DOI: 10.1186/s12876-023-02881-6.
Mo S, Jin B, Tseng Y, Lin L, Lin L, Shen X
J Transl Med. 2023; 21(1):466.
PMID: 37443022
PMC: 10347743.
DOI: 10.1186/s12967-023-04326-w.
Zhang H, Zhao S, Cao Z
Front Immunol. 2022; 13:1001055.
PMID: 36389673
PMC: 9651941.
DOI: 10.3389/fimmu.2022.1001055.
Venner J, Bernstein C
Gastroenterol Rep (Oxf). 2022; 10:goac061.
PMID: 36381225
PMC: 9642324.
DOI: 10.1093/gastro/goac061.
Zhou Z, Chen H, Shen Y, Huang H
Evid Based Complement Alternat Med. 2022; 2022:3166416.
PMID: 35497920
PMC: 9054452.
DOI: 10.1155/2022/3166416.
Physician education can minimize inappropriate steroid use in patients with inflammatory bowel disease: the ACTION study.
Park Y, Choi C, Kim H, Moon H, Kim D, Kim J
Intest Res. 2022; 20(4):452-463.
PMID: 35263960
PMC: 9650332.
DOI: 10.5217/ir.2021.00125.
Effect of NUDT15 polymorphisms on early hematological safety of low-dose azathioprine in Chinese patients with pemphigus vulgaris: A prospective cohort study.
Zhou X, Cheng L, Wang Y, Gou H, Ju K, Lan T
J Dermatol. 2021; 49(4):402-410.
PMID: 34866237
PMC: 9299774.
DOI: 10.1111/1346-8138.16265.
A Review of Hyperbaric Oxygen Therapy for Inflammatory Bowel Disease.
Alenazi N, Alsaeed H, Alsulami A, Alanzi T
Int J Gen Med. 2021; 14:7099-7105.
PMID: 34729019
PMC: 8554584.
DOI: 10.2147/IJGM.S336678.
Use of thiopurines in inflammatory bowel disease: an update.
Singh A, Mahajan R, Kedia S, Dutta A, Anand A, Bernstein C
Intest Res. 2021; 20(1):11-30.
PMID: 33845546
PMC: 8831775.
DOI: 10.5217/ir.2020.00155.
Protective Mechanism of Butanol Extract and Its Nano-Formulations against Ulcerative Colitis in Rats as Revealed via Biochemical and Metabolomic Assays.
Abdallah H, Ammar N, Abdelhameed M, El Gendy A, Ragab T, Abd-ElGawad A
Biology (Basel). 2020; 9(8).
PMID: 32751448
PMC: 7463518.
DOI: 10.3390/biology9080195.
The New Proactive Approach and Precision Medicine in Crohn's Disease.
Zittan E, Gralnek I, Berns M
Biomedicines. 2020; 8(7).
PMID: 32635316
PMC: 7400127.
DOI: 10.3390/biomedicines8070193.
Molecules from American Ginseng Suppress Colitis through Nuclear Factor Erythroid-2-Related Factor 2.
Chaparala A, Tashkandi H, Chumanevich A, Witalison E, Windust A, Cui T
Nutrients. 2020; 12(6).
PMID: 32575883
PMC: 7353434.
DOI: 10.3390/nu12061850.
Strictureplasty for Crohn's disease of the small bowel in the biologic era: long-term outcomes and risk factors for recurrence.
Rottoli M, Tanzanu M, Manzo C, Bacchi Reggiani M, Gionchetti P, Rizzello F
Tech Coloproctol. 2020; 24(7):711-720.
PMID: 32306308
DOI: 10.1007/s10151-020-02208-7.
New developments in ulcerative colitis: latest evidence on management, treatment, and maintenance.
Tripathi K, Feuerstein J
Drugs Context. 2019; 8:212572.
PMID: 31065290
PMC: 6490072.
DOI: 10.7573/dic.212572.
Efficacy and safety of abrilumab, an α4β7 integrin inhibitor, in Japanese patients with moderate-to-severe ulcerative colitis: a phase II study.
Hibi T, Motoya S, Ashida T, Sai S, Sameshima Y, Nakamura S
Intest Res. 2019; 17(3):375-386.
PMID: 30739435
PMC: 6667363.
DOI: 10.5217/ir.2018.00141.
Gene Signature-Based Approach Identified MEK1/2 as a Potential Target Associated With Relapse After Anti-TNFα Treatment for Crohn's Disease.
Gamo K, Okuzono Y, Yabuki M, Ochi T, Sugimura K, Sato Y
Inflamm Bowel Dis. 2018; 24(6):1251-1265.
PMID: 29669006
PMC: 6176896.
DOI: 10.1093/ibd/izy079.
Predictive role of NUDT15 variants on thiopurine-induced myelotoxicity in Asian inflammatory bowel disease patients.
Sutiman N, Chen S, Ling K, Chuah S, Leong W, Nadiger V
Pharmacogenomics. 2017; 19(1):31-43.
PMID: 29210335
PMC: 5753614.
DOI: 10.2217/pgs-2017-0147.
Macronutrient Intake and Risk of Crohn's Disease: Systematic Review and Dose-Response Meta-Analysis of Epidemiological Studies.
Zeng L, Hu S, Chen P, Wei W, Tan Y
Nutrients. 2017; 9(5).
PMID: 28505133
PMC: 5452230.
DOI: 10.3390/nu9050500.
Human β-Defensin 2 in Primary Sclerosing Cholangitis.
Chang C, Lleo A, Kananurak A, Grizzi F, Tsuneyama K, Invernizzi P
Clin Transl Gastroenterol. 2017; 8(3):e80.
PMID: 28300822
PMC: 5387757.
DOI: 10.1038/ctg.2017.8.
Therapeutic efficacy of an elemental diet for patients with crohn's disease and its association with amino acid metabolism.
Nakano M, Tominaga K, Hoshino A, Sugaya T, Kanke K, Hiraishi H
Saudi J Gastroenterol. 2017; 23(1):20-27.
PMID: 28139496
PMC: 5329972.
DOI: 10.4103/1319-3767.199110.
